Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × ARRY-334543 × Clear all

NCT03130790 2022-02-15

Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms